Jump to Navigation
Donate

Search form

  • Home
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
Home
  • About Us
    • Bios
      • Ellen V. Sigal
      • Marlene A. Malek
      • Jeff Allen
      • Ryan Hohman
      • Berrett Stradford
      • Heather Chaney
      • Samantha Roberts
      • Jessica Walrath
      • Hilary Downey
      • Ryan Dull
    • Board of Directors
    • Scientific Advisory Board
    • Annual Reports
    • Friends Documents
      • Conference on Clinical Cancer Research
      • Scientific White Papers
      • Annual Reports
      • Policy Documents
    • Jobs & Internships
  • Science & Policy
    • Presentations
    • FDA & Regulatory Policy
      • PDUFA
      • Approval Mechanisms
      • Breakthrough Therapies
    • Health & Research Policy
      • NIH and NCI
      • Comparative Effectiveness Research and PCORI
      • Affordable Care Act
      • Master Protocol
  • News
    • Press Releases
    • Congressional Updates
    • FDA and NIH/NCI Appropriations
    • Hearings
      • House of Representatives
      • Senate
  • Conferences & Events
    • Conference on Clinical Cancer Research
      • 2012 Conference
      • 2011 Conference
      • 2010 Conference
      • 2009 Conference
      • 2008 Conference
    • Upcoming Events
    • Event Archive
  • Patient Resources
    • Cancer Statistics
    • Prevention, Detection, and Diagnosis
    • Information by Cancer Type
    • Clinical Trials
    • Cancer Drug Approval
    • Cancer Centers
    • Agencies, Advocacy Group & Organizations
  • Support Friends
    • Donate
    • Annual Reception
    • Policy on Corporate Relationships

You are here

Home teal green arrow Science & Policy teal green arrow Presentations

Presentations

Click on a link below to download the corresponding presentation PDF:

The Future of Clinical Trials: New Model to Enhance Efficiency by Jeff Allen, PhD (April 2013)

Innovative Drug Approvals: Breakthrough Therapies Ryan M. Hohman, JD, MPA (April 2013)

Assessment of PDUFA and FDASIA Implementation: Breakthrough Therapies (April 2013)

Presentation to the President's Cancer Panel by Ellen Sigal, PhD (December 2010)

The New Role of Academia in Drug Discovery & Development (December 2010)

DIA Global Forum Artcile on Drug Information, Jeff Allen, PhD (October 2010)

Testimony at National Dialogue for Healthcare Innovation, Ryan Hohman, JD (October 2010)

Presentation by Ellen Sigal, PhD, on CER at AACR Annual Meeting (April 2010)

View More

Past Events

April 9, 2013
'Breakthrough Therapy' Designation and Its Implications for Accelerating Oncology Drug Development
March 12, 2013
Design of a Lung Cancer Master Protocol
February 6, 2013
The Blueprint of Medical Research: How New Medicines Get from the Lab to the Patient

Connect With Us

Newsletter Sign-Up

Sign up for information and updates:

Twitter

Follow Us @CancerResrch
Loading...
Footer
  • Home
    • Contact Us
    • Twitter
    • Donate
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • About Us
    • Bios
    • Board of Directors
    • Scientific Advisory Board
    • Annual Reports
    • Friends Documents
    • Jobs & Internships
  • Science & Policy
    • Presentations
    • FDA & Regulatory Policy
    • Health & Research Policy
  • News
    • Press Releases
    • Congressional Updates
    • FDA and NIH/NCI Appropriations
    • Hearings
  • Conferences & Events
    • Conference on Clinical Cancer Research
    • Upcoming Events
    • Event Archive
  • Patient Resources
    • Cancer Statistics
    • Prevention, Detection, and Diagnosis
    • Information by Cancer Type
    • Clinical Trials
    • Cancer Drug Approval
    • Cancer Centers
    • Agencies, Advocacy Group & Organizations
  • Support Friends
    • Donate
    • Annual Reception
    • Policy on Corporate Relationships

FRIENDS OF CANCER RESEARCH
1800 M Street NW Suite 1050 | Washington, DC 20036
202.944.6700

HOME   |   SITE MAP   |   PRIVACY POLICY   |   TERMS & CONDITIONS

© Copyright 2013 | All Rights Reserved | Web Design by Blue Water Media